EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Myricetin reduces neutrophil extracellular trap release in a rat model of rheumatoid arthritis, which is associated with a decrease in disease severity

Yiqin Shu, Rui Yang, Huijie Wen, Qiannan Dong, Zhiqi Chen, Yang Xiang, Hao Wu iD

Innate Immunity · 2024

DOI: 10.1177/17534259241255439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Innate Immunity, 2024. Verfasst von Yiqin Shu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Hubei Enshi College, Enshi, China. Hauptthemen laut MEDLINE: Extracellular Traps, Arthritis, Rheumatoid, Flavonoids, Protein-Arginine Deiminase Type 4. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hubei Provincial Department of Education, National Natural Science Foundation of China, 湖北恩施学院教师类项目.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic disease characterized by joint inflammation and severe disability. However, there is a lack of safe and effective drugs for treating RA. In our previous study, we discovered that myricetin (MC) and celecoxib have a synergistic effect in the treatment of RA. We conducted in vitro and in vivo experiments to further investigate the effects and mechanisms of action of MC. Our findings demonstrated that MC treatment effectively reduced the release of neutrophil extracellular traps (NETs) and alleviated the inflammatory response in RA. Mechanistic studies showed that MC prevents the entry of PADI4 and MPO into the cell nucleus, thereby protecting DNA from decondensation. In a rat arthritis model, MC improved histological changes in ankle joints and suppressed NET-related signaling factors. In conclusion, MC protects the ankle joints against arthritis by inhibiting MPO and PADI4, thereby reducing NET release. The pharmacological mechanism of MC in RA involves the inhibition of NET release.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular TrapsArthritis, RheumatoidFlavonoidsProtein-Arginine Deiminase Type 4Disease Models, AnimalNeutrophilsPeroxidaseAnimalsRatsHumansProtein-Arginine DeiminasesArthritis, ExperimentalMaleRats, Sprague-DawleyCelecoxibCells, CulturedSeverity of Illness Index

Stichwörter der Autor:innen

Neutrophil extracellular trapsmyeloperoxidasemyricetinpeptidylarginine deiminase 4rheumatoid arthritis

Substanzen

myricetinFlavonoidsProtein-Arginine Deiminase Type 4PeroxidaseProtein-Arginine DeiminasesCelecoxibPADI4 protein, human

Autor:innen und Institutionen

  • Medical College of Hubei Enshi College, Enshi, China.
  • Institute of anti-rheumatism Tujia Medicine, Enshi, China.
  • Hubei Provincial Key Laboratory of Rheumatic Disease Development and Intervention, Enshi, China.

ORCID-Profile: Hao Wu

Förderung

  • Hubei Provincial Department of Education
  • National Natural Science Foundation of China
  • 湖北恩施学院教师类项目

Zitieren

APA

Shu, Y., Yang, R., Wen, H., Dong, Q., Chen, Z., Xiang, Y., & Wu, H. (2024). Myricetin reduces neutrophil extracellular trap release in a rat model of rheumatoid arthritis, which is associated with a decrease in disease severity. Innate Immunity. https://doi.org/10.1177/17534259241255439

Vancouver

Shu Y, Yang R, Wen H, Dong Q, Chen Z, Xiang Y, et al. Myricetin reduces neutrophil extracellular trap release in a rat model of rheumatoid arthritis, which is associated with a decrease in disease severity. Innate Immunity. 2024. doi:10.1177/17534259241255439

BibTeX
@article{Shu2024,
  author = {Shu, Yiqin and Yang, Rui and Wen, Huijie and Dong, Qiannan and Chen, Zhiqi and Xiang, Yang and Wu, Hao},
  title = {Myricetin reduces neutrophil extracellular trap release in a rat model of rheumatoid arthritis, which is associated with a decrease in disease severity},
  journal = {Innate Immunity},
  year = {2024},
  doi = {10.1177/17534259241255439}
}
Kostenlos starten →